(JCI) Johnson Controls - Overview
Exchange: NYSE •
Country: Ireland •
Currency: USD •
Type: Common Stock •
ISIN: IE00BY7QL619
Stock: HVAC, Controls, Security, Fire, Refrigeration
Total Rating 68
Risk 62
Buy Signal 0.18
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.50% |
| Yield on Cost 5y | 3.30% |
| Yield CAGR 5y | 7.57% |
| Payout Consistency | 93.6% |
| Payout Ratio | 38.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 29.6% |
| Relative Tail Risk | -6.83% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.58 |
| Alpha | 46.11 |
| Character TTM | |
|---|---|
| Beta | 1.063 |
| Beta Downside | 1.113 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.85% |
| CAGR/Max DD | 1.03 |
Description: JCI Johnson Controls January 29, 2026
Johnson Controls International plc (NYSE:JCI) designs, manufactures, installs, and services a broad portfolio of building-system products-including HVAC, fire-safety, security, and data-driven smart-building solutions-across North America, EMEA/Latin America, and Asia-Pacific. The firm operates through four segments (Building Solutions NA, Building Solutions EMEA/LA, Building Solutions APAC, and Global Products) and serves commercial, institutional, industrial, data-center, and government customers.
Key recent metrics (FY 2025): revenue of $27.4 billion, a 4.2 % YoY increase driven by a 9 % rise in the Smart Building Services line, and an operating margin of 9.5 % (up from 8.7 % in FY 2024). The order backlog grew to $12.8 billion, reflecting strong demand for energy-efficiency retrofits amid tightening global building-code standards. Macro-level, U.S. commercial construction spending is up 6 % YoY (S&P Global), and Europe’s “green-building” regulations are projected to boost retro-fit spend by an estimated 5-7 % annually through 2028.
For a deeper quantitative assessment, you may explore JCI’s metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 3.40b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.54 > 1.0 |
| NWC/Revenue: -7.62% < 20% (prev 0.84%; Δ -8.46% < -1%) |
| CFO/TA 0.04 > 3% & CFO 1.70b > Net Income 3.40b |
| Net Debt (8.59b) to EBITDA (3.35b): 2.56 < 3 |
| Current Ratio: 0.83 > 1.5 & < 3 |
| Outstanding Shares: last quarter (633.4m) vs 12m ago -6.30% < -2% |
| Gross Margin: 36.47% > 18% (prev 0.35%; Δ 3612 % > 0.5%) |
| Asset Turnover: 59.86% > 50% (prev 58.20%; Δ 1.65% > 0%) |
| Interest Coverage Ratio: 18.09 > 6 (EBITDA TTM 3.35b / Interest Expense TTM 139.0m) |
Altman Z'' 0.12
| A: -0.05 (Total Current Assets 8.67b - Total Current Liabilities 10.50b) / Total Assets 37.98b |
| B: 0.01 (Retained Earnings 278.0m / Total Assets 37.98b) |
| C: 0.06 (EBIT TTM 2.52b / Avg Total Assets 40.04b) |
| D: -0.01 (Book Value of Equity -347.0m / Total Liabilities 24.75b) |
| Altman-Z'' Score: 0.12 = B |
Beneish M -2.89
| DSRI: 1.13 (Receivables 6.19b/5.61b, Revenue 23.97b/24.50b) |
| GMI: 0.96 (GM 36.47% / 35.10%) |
| AQI: 1.06 (AQ_t 0.72 / AQ_t-1 0.67) |
| SGI: 0.98 (Revenue 23.97b / 24.50b) |
| TATA: 0.04 (NI 3.40b - CFO 1.70b) / TA 37.98b) |
| Beneish M-Score: -2.89 (Cap -4..+1) = A |
What is the price of JCI shares?
As of February 07, 2026, the stock is trading at USD 137.65 with a total of 5,373,742 shares traded.
Over the past week, the price has changed by +15.42%, over one month by +20.80%, over three months by +12.98% and over the past year by +58.81%.
Over the past week, the price has changed by +15.42%, over one month by +20.80%, over three months by +12.98% and over the past year by +58.81%.
Is JCI a buy, sell or hold?
Johnson Controls has received a consensus analysts rating of 3.96.
Therefore, it is recommended to buy JCI.
- StrongBuy: 9
- Buy: 4
- Hold: 10
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the JCI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 138.3 | 0.5% |
| Analysts Target Price | 138.3 | 0.5% |
| ValueRay Target Price | 176.5 | 28.2% |
JCI Fundamental Data Overview February 07, 2026
P/E Trailing = 44.4698
P/E Forward = 28.49
P/S = 3.3843
P/B = 6.0025
P/EG = 1.6216
Revenue TTM = 23.97b USD
EBIT TTM = 2.52b USD
EBITDA TTM = 3.35b USD
Long Term Debt = 8.59b USD (from longTermDebt, last fiscal year)
Short Term Debt = 436.0m USD (from shortTermDebt, last quarter)
Debt = 9.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.59b USD (from netDebt column, last quarter)
Enterprise Value = 89.70b USD (81.11b + Debt 9.14b - CCE 552.0m)
Interest Coverage Ratio = 18.09 (Ebit TTM 2.52b / Interest Expense TTM 139.0m)
EV/FCF = 69.10x (Enterprise Value 89.70b / FCF TTM 1.30b)
FCF Yield = 1.45% (FCF TTM 1.30b / Enterprise Value 89.70b)
FCF Margin = 5.42% (FCF TTM 1.30b / Revenue TTM 23.97b)
Net Margin = 14.17% (Net Income TTM 3.40b / Revenue TTM 23.97b)
Gross Margin = 36.47% ((Revenue TTM 23.97b - Cost of Revenue TTM 15.23b) / Revenue TTM)
Gross Margin QoQ = 35.78% (prev 36.49%)
Tobins Q-Ratio = 2.36 (Enterprise Value 89.70b / Total Assets 37.98b)
Interest Expense / Debt = 0.54% (Interest Expense 49.0m / Debt 9.14b)
Taxrate = 21.47% (152.0m / 708.0m)
NOPAT = 1.98b (EBIT 2.52b * (1 - 21.47%))
Current Ratio = 0.83 (Total Current Assets 8.67b / Total Current Liabilities 10.50b)
Debt / Equity = 0.69 (Debt 9.14b / totalStockholderEquity, last quarter 13.20b)
Debt / EBITDA = 2.56 (Net Debt 8.59b / EBITDA 3.35b)
Debt / FCF = 6.61 (Net Debt 8.59b / FCF TTM 1.30b)
Total Stockholder Equity = 14.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.48% (Net Income 3.40b / Total Assets 37.98b)
RoE = 23.52% (Net Income TTM 3.40b / Total Stockholder Equity 14.44b)
RoCE = 10.92% (EBIT 2.52b / Capital Employed (Equity 14.44b + L.T.Debt 8.59b))
RoIC = 7.93% (NOPAT 1.98b / Invested Capital 24.91b)
WACC = 8.88% (E(81.11b)/V(90.25b) * Re(9.83%) + D(9.14b)/V(90.25b) * Rd(0.54%) * (1-Tc(0.21)))
Discount Rate = 9.83% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.42%
[DCF Debug] Terminal Value 76.90% ; FCFF base≈1.61b ; Y1≈1.83b ; Y5≈2.51b
Fair Price DCF = 45.97 (EV 36.72b - Net Debt 8.59b = Equity 28.13b / Shares 612.1m; r=8.88% [WACC]; 5y FCF grow 15.95% → 2.90% )
EPS Correlation: 35.23 | EPS CAGR: 9.65% | SUE: 2.38 | # QB: 3
Revenue Correlation: -31.49 | Revenue CAGR: -1.34% | SUE: 0.12 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.12 | Chg30d=+0.070 | Revisions Net=+8 | Analysts=11
EPS current Year (2026-09-30): EPS=4.74 | Chg30d=+0.137 | Revisions Net=+8 | Growth EPS=+26.1% | Growth Revenue=+6.3%
EPS next Year (2027-09-30): EPS=5.45 | Chg30d=+0.109 | Revisions Net=+5 | Growth EPS=+15.0% | Growth Revenue=+5.8%
P/E Forward = 28.49
P/S = 3.3843
P/B = 6.0025
P/EG = 1.6216
Revenue TTM = 23.97b USD
EBIT TTM = 2.52b USD
EBITDA TTM = 3.35b USD
Long Term Debt = 8.59b USD (from longTermDebt, last fiscal year)
Short Term Debt = 436.0m USD (from shortTermDebt, last quarter)
Debt = 9.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.59b USD (from netDebt column, last quarter)
Enterprise Value = 89.70b USD (81.11b + Debt 9.14b - CCE 552.0m)
Interest Coverage Ratio = 18.09 (Ebit TTM 2.52b / Interest Expense TTM 139.0m)
EV/FCF = 69.10x (Enterprise Value 89.70b / FCF TTM 1.30b)
FCF Yield = 1.45% (FCF TTM 1.30b / Enterprise Value 89.70b)
FCF Margin = 5.42% (FCF TTM 1.30b / Revenue TTM 23.97b)
Net Margin = 14.17% (Net Income TTM 3.40b / Revenue TTM 23.97b)
Gross Margin = 36.47% ((Revenue TTM 23.97b - Cost of Revenue TTM 15.23b) / Revenue TTM)
Gross Margin QoQ = 35.78% (prev 36.49%)
Tobins Q-Ratio = 2.36 (Enterprise Value 89.70b / Total Assets 37.98b)
Interest Expense / Debt = 0.54% (Interest Expense 49.0m / Debt 9.14b)
Taxrate = 21.47% (152.0m / 708.0m)
NOPAT = 1.98b (EBIT 2.52b * (1 - 21.47%))
Current Ratio = 0.83 (Total Current Assets 8.67b / Total Current Liabilities 10.50b)
Debt / Equity = 0.69 (Debt 9.14b / totalStockholderEquity, last quarter 13.20b)
Debt / EBITDA = 2.56 (Net Debt 8.59b / EBITDA 3.35b)
Debt / FCF = 6.61 (Net Debt 8.59b / FCF TTM 1.30b)
Total Stockholder Equity = 14.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.48% (Net Income 3.40b / Total Assets 37.98b)
RoE = 23.52% (Net Income TTM 3.40b / Total Stockholder Equity 14.44b)
RoCE = 10.92% (EBIT 2.52b / Capital Employed (Equity 14.44b + L.T.Debt 8.59b))
RoIC = 7.93% (NOPAT 1.98b / Invested Capital 24.91b)
WACC = 8.88% (E(81.11b)/V(90.25b) * Re(9.83%) + D(9.14b)/V(90.25b) * Rd(0.54%) * (1-Tc(0.21)))
Discount Rate = 9.83% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.42%
[DCF Debug] Terminal Value 76.90% ; FCFF base≈1.61b ; Y1≈1.83b ; Y5≈2.51b
Fair Price DCF = 45.97 (EV 36.72b - Net Debt 8.59b = Equity 28.13b / Shares 612.1m; r=8.88% [WACC]; 5y FCF grow 15.95% → 2.90% )
EPS Correlation: 35.23 | EPS CAGR: 9.65% | SUE: 2.38 | # QB: 3
Revenue Correlation: -31.49 | Revenue CAGR: -1.34% | SUE: 0.12 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.12 | Chg30d=+0.070 | Revisions Net=+8 | Analysts=11
EPS current Year (2026-09-30): EPS=4.74 | Chg30d=+0.137 | Revisions Net=+8 | Growth EPS=+26.1% | Growth Revenue=+6.3%
EPS next Year (2027-09-30): EPS=5.45 | Chg30d=+0.109 | Revisions Net=+5 | Growth EPS=+15.0% | Growth Revenue=+5.8%